April 28, 2020
Oncopeptides Annual Report 2019
Media
April 28, 2020
Interim Report Q1 2020
April 28, 2020
Vicore Pharma gets regulatory approval to start phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection
April 22, 2020
GenSight Biologics will hold its General Meeting on April 29, 2020 behind closed doors
April 22, 2020
Annual General Meeting in Oncopeptides AB (publ)
April 22, 2020
Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology
April 21, 2020
GenSight Biologics Reports Cash Position as of March 31, 2020 and Provides Operational Update
April 20, 2020
Strongbridge Biopharma plc to Host First Quarter 2020 Financial Results Conference Call on May 6, 2020
April 17, 2020
BONESUPPORT announces – De Novo application for CERAMENT G has been submitted to the FDA
April 16, 2020
James Noble appointed as Chairman of the Board